Form 4: Steven Felsher Acquires Shares and Warrants in Modular Medical, Inc. via Private Placement

Director Steven Felsher reports acquisition of Modular Medical, Inc. shares and warrants through a private placement.

Summary

• On March 20, 2025, Steven Felsher, a director of Modular Medical, Inc., acquired 62,500 shares of common stock and warrants to purchase 31,250 shares through a private placement.
• The transaction involved the purchase of 31,250 units at $1.92 per unit, with each unit consisting of two shares of common stock and one warrant.
• The warrants are immediately exercisable at $1.12 and expire four years from the issuance date.
• Following the reported transactions, Felsher's beneficial ownership includes 190,927 shares of common stock and 31,250 warrants.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing reflecting an insider transaction. The purchase could be seen as a positive signal, but it's not overwhelmingly so.

Positives

• Insider buying can sometimes be seen as a positive signal, indicating confidence in the company's future prospects.

Risks

• Private placements can sometimes dilute existing shareholders' equity.

Future Outlook

The document does not contain specific forward-looking statements beyond the warrant expiration date.

Industry Context

This filing is a routine disclosure related to insider transactions, common in the biotech and medical device industries where stock options and warrants are frequently used as part of compensation packages.

Comparison to Industry Standards

• Insider transactions are a common occurrence in publicly traded companies, particularly in the biotechnology and medical device sectors.
• Companies like Insulet and Dexcom also see regular Form 4 filings from their executives and directors.
• The size and frequency of these transactions can vary widely based on individual circumstances and company policies.

Stakeholder Impact

• The transaction could have a minor impact on shareholders due to potential dilution from the exercise of warrants.

Key Dates

Keywords

Form 4, insider trading, beneficial ownership, warrants, private placement, Modular Medical, Inc., MODD, Steven Felsher, director, acquisition